Cited by 1,086Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchPrion Diseases and Protein Misfolding

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Open access

Hensley, K, Carney, J M, Mattson, M P, Aksenova, M, Harris, M, Wu, J F, Floyd, R A, Butterfield, D A·1994·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.91.8.3270PMC PMC43558

Open this paper in CoChat — free account

Abstract

beta-Amyloid is a 39- to 43-amino-acid neurotoxic peptide that aggregates to form the core of Alzheimer disease-associated senile (amyloid) plaques. No satisfactory hypothesis has yet been proposed to explain the mechanism of beta-amyloid aggregation and toxicity. We present mass spectrometric and electron paramagnetic resonance spin trapping evidence that beta-amyloid, in aqueous solution, fragments and generates free radical peptides. beta-Amyloid fragments, at concentrations that previously have been shown to be neurotoxic to cultured neurons, can inactivate oxidation-sensitive glutamine synthetase and creatine kinase enzymes. Also, salicylate hydroxylation assays indicate that reactive oxygen species are generated by the beta-amyloid-(25-35) fragment during cell-free incubation. These results are formulated into a free radical-based unifying hypothesis for neurotoxicity of beta-amyloid and are discussed with reference to membrane molecular alterations in Alzheimer disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.91.8.3270

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Self-citation
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain.
Oliver, C., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M., & Floyd, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5144 · Cited by 771
Self-citation
Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone.
Carney, J. M., Starke-Reed, P. E., Oliver, C., Landum, R. W., Cheng, M. S., Wu, J., & Floyd, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3633 · Cited by 724
Self-citation
Free radical damage to protein and DNA: Mechanisms involved and relevant observations on brain undergoing oxidative stress
Floyd, R. A., & Carney, J. M. (1992) · Annals of Neurology · doi:10.1002/ana.410320706 · Cited by 539
Self-citation
β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I. M., Smith‐Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
Self-citation

Flagged first, then by citations

Show all 23 references

Research works printed but not linked: 5

[9]Oliver, C. N., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M. & Floyd, R. A. (1990) Proc. Natl. Acad. Sci. USA 87, 5144–5147.
[11]Miller, R. E., Hadenberg, R. & Gersham, H. (1978) Proc. Natl. Acad. Sci. USA 75, 1418–1422.
[13]Janzen, E. G. (1980) in Free Radicals in Biology, ed. Pryor, W. A. (Academic, New York), Vol. 4, pp. 115-154.
[19]Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Landum, R. W., Cheng, M. S., Wu, J. F. & Floyd, R. A. (1991) Proc. Natl. Acad. Sci. USA 88, 3633–3636.
[27]Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A. & Markesbery, W. R. (1991) Proc. Natl. Acad. Sci. USA 88, 10540–10543.

Sorted by citations

Items 301–400 of 1,000

Huperzine A and tacrine attenuate ?-amyloid peptide-induced oxidative injury
Xiao, X., Wang, R., & Tang, X. C. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000901)61:5 · Cited by 101
Why neurons die: Cell death in the nervous system
Hutchins, J. B., & Barger, S. W. (1998) · The Anatomical Record · doi:10.1002/(sici)1097-0185(199806)253:3 · Cited by 100
Oxidative Stress and Lysosomes: CNS-Related Consequences and Implications for Lysosomal Enhancement Strategies and Induction of Autophagy
Butler, D., & Bahr, B. A. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.185 · Cited by 104
Oxidative Stress, Antioxidants, and Alzheimer Disease
Rottkamp, C. A., Nunomura, A., Raina, A. K., Sayre, L. M., Perry, G. L., & Smith, M. A. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00010 · Cited by 100
The Free Radical Antioxidant Vitamin E Protects Cortical Synaptosomal Membranes from Amyloid β-Peptide(25-35) Toxicity But Not from Hydroxynonenal Toxicity: Relevance to the Free Radical Hypothesis of Alzheimer's Disease
Subramaniam, R., Koppal, T., Green, M., Yatin, S. M., Jordan, B., Drake, J., & Butterfield, D. A. (1998) · Neurochemical Research · doi:10.1023/a:1020754807671 · Cited by 101
Self-citation
Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation
Eckert, A., Steiner, B., Marques, C. A., Leutz, S., Romig, H., Haass, C., & Müller, W. E. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1064 · Cited by 101
Effects of Flavonoid Compounds on β-amyloid-peptide-induced Neuronal Death in Cultured Mouse Cortical Neurons
Choi, S., Kim, B. C., Cho, Y.-H., Choi, K., Chang, J. Y., Park, M., Kim, M., Cho, K.-H., & Kim, J.-K. (2014) · Chonnam Medical Journal · doi:10.4068/cmj.2014.50.2.45 · Cited by 98
The neuroprotective effects of tanshinone IIA on β-amyloid-induced toxicity in rat cortical neurons
Liu, T., Jin, H., Sun, Q., Xu, J., & Hu, H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.08.013 · Cited by 99
N‐Acetyl‐ l ‐cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on β‐amyloid secretion and tau phosphorylation
Olivieri, G., Baysang, G., Meier, F., Müller-Spahn, F., Stähelin, H. B., Brockhaus, M., & Brack, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00090.x · Cited by 98
A Monoclonal Antibody to Amyloid Precursor Protein Induces Neuronal Apoptosis
Rohn, T. T., Ivins, K. J., Bahr, B. A., Cotman, C. W., & Cribbs, D. H. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742331.x · Cited by 98
Inhibition of γ-secretase activity reduces Aβ production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease
Sheng, B., Gong, K., Niu, Y., Liu, L., Yan, Y., Lu, G., Zhang, L., Hu, M., Zhao, N., Zhang, X., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.018 · Cited by 98
Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories
Butterfield, D. A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101049 · Cited by 98
Self-citation
EEG Alterations in Subjects at High Familial Risk for Alzheimer’s Disease
Пономарева, Н. В., Selesneva, N. D., & Jarikov, G. A. (2003) · Neuropsychobiology · doi:10.1159/000073633 · Cited by 101
Neuroprotective approaches in experimental models of β-Amyloid neurotoxicity: Relevance to Alzheimer's disease
Harkany, T., Hortobágyi, T., Sasvári, M., Kónya, C., Penke, B., Luiten, P. G. M., & Nyakas, C. J. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00058-5 · Cited by 97
Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease
Robinson, S. R. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10057 · Cited by 96
Glutamine synthetase, hemoglobin α-chain, and macrophage migration inhibitory factor binding to amyloid β-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer’s disease brain by immunoprecipitation
Oyama, R., Yamamoto, H., & Titani, K. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00057-1 · Cited by 96
Alzheimer's amyloid β-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E
Yatin, S. M., Yatin, M., Aulick, T., Ain, K. B., & Butterfield, D. A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00101-9 · Cited by 97
Self-citation
Amyloid β-protein precursor: new clues to the genesis of Alzheimer's disease
Selkoe, D. J. (1994) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(94)90014-0 · Cited by 96
Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration
Cassano, T., Pace, L., Bedse, G., Lavecchia, A. M., Marco, F. D., Gaetani, S., & Serviddio, G. (2015) · Current Alzheimer Research · doi:10.2174/1567205013666151218132725 · Cited by 96
Nanoparticle and Iron Chelators as a Potential Novel Alzheimer Therapy
Liu, G., Men, P., Perry, G. L., & Smith, M. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-029-8_8 · Cited by 95
Amyloid β Peptides Do Not Form Peptide-derived Free Radicals Spontaneously, but Can Enhance Metal-catalyzed Oxidation of Hydroxylamines to Nitroxides
Dikalov, S., Vitek, M. P., Maples, K. R., & Mason, R. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9392 · Cited by 96
K+ channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity
Goodman, Y., & Mattson, M. P. (1996) · Brain Research · doi:10.1016/0006-8993(95)01367-9 · Cited by 96
Self-citation
Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study
Cherubini, A., Martin, A., Andres-Lacueva, C., Di Iorio, A., Lamponi, M., Mecocci, P., Bartali, B., Corsi, A., Senin, U., & Ferrucci, L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.002 · Cited by 94
Mechanism and kinetics studies on the antioxidant activity of sinapinic acid
Galano, A., Francisco‐Márquez, M., & Alvarez-Idaboy, J. R. (2011) · Physical Chemistry Chemical Physics · doi:10.1039/c1cp20722a · Cited by 94
Microglial Contribution to Oxidative Stress in Alzheimer's Disease
Colton, C. A., Chernyshev, O. N., Gilbert, D. L., & Vitek, M. P. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06195.x · Cited by 96
The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease
Drew, S. C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00317 · Cited by 93
Rational targeting for prion therapeutics
Mallucci, G. R., & Collinge, J. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1584 · Cited by 96
Olanzapine and quetiapine protect PC12 cells from β-amyloid peptide25-35-induced oxidative stress and the ensuing apoptosis
Wang, H., Xu, H., Dyck, L. E., & Li, X. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20570 · Cited by 93
Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity
Ran, Q., Gu, M., Remmen, H. V., Strong, R., Roberts, J. L., & Richardson, A. G. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20868 · Cited by 95
Products of Cu(II)-catalyzed oxidation in the presence of hydrogen peroxide of the 1–10, 1–16 fragments of human and mouse β-amyloid peptide
Kowalik-Jankowska, T., Ruta, M., Wiśniewska, K., Łankiewicz, L., & Dyba, M. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.03.001 · Cited by 92
Autophagy, Cellular Aging and Age-related Human Diseases
Cheon, S. Y., Kim, H. J., Rubinsztein, D. C., & Lee, J. E. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.6.643 · Cited by 95
Mechanism of the OH Radical Scavenging Activity of Nordihydroguaiaretic Acid: A Combined Theoretical and Experimental Study
Galano, A., Macías-Ruvalcaba, N. A., Medina‐Campos, O. N., & Pedraza‐Chaverrí, J. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp912001c · Cited by 94
Cerebrovascular Effects of Amyloid-ß Peptides: Mechanisms and Implications for Alzheimer's Dementia
Iadecola, C. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025092617651 · Cited by 92
Inhibitors of free radical formation fail to attenuate direct β‐amyloid25–35 peptide‐mediated neurotoxicity in rat hippocampal cultures
Lockhart, B. P., Bénicourt, C., Junien, J., & Privat, A. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390416 · Cited by 92
Electron paramagnetic resonance investigations of free radical-induced alterations in neocortical synaptosomal membrane protein infrastructure
Hensley, K., Carney, J. M., Hall, N. C., Shaw, W., & Butterfield, D. A. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90018-3 · Cited by 92
Self-citation
Brain Activation of SIRT1: Role in Neuropathology
Paraíso, A. F., Mendes, K. L., & Santos, S. H. S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8459-x · Cited by 91
Canolol: A Promising Chemical Agent against Oxidative Stress
Galano, A., Francisco‐Márquez, M., & Alvarez-Idaboy, J. R. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp2022105 · Cited by 93
Increased Susceptibility of Alzheimer's Disease Temporal Cortex to Oxygen Free Radical-Mediated Processes
McIntosh, L. J., Trush, M. A., & Troncoso, J. C. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00573-4 · Cited by 91
Flavones from Scutellaria baicalensis Georgi attenuate apoptosis and protein oxidation in neuronal cell lines
Choi, J., Conrad, C. C., Malakowsky, C. A., Talent, J. M., Yuan, C., & Gracy, R. W. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00217-9 · Cited by 91
Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction
Tomiyama, T., Kaneko, H., Kataoka, K.-I., Asano, S., & Endo, N. (1997) · Biochemical Journal · doi:10.1042/bj3220859 · Cited by 91
Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease
Raefsky, S. M., Furman, R., Milne, G., Pollock, E., Axelsen, P., Mattson, M. P., & Shchepinov, M. S. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.02.024 · Cited by 90
Self-citation
Centella asiatica Attenuates Amyloid-β-Induced Oxidative Stress and Mitochondrial Dysfunction
Gray, N. E., Sampath, H., Zweig, J. A., Quinn, J. F., & Soumyanath, A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142217 · Cited by 93
The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Aβ peptides
Liao, M. Q., Tzeng, Y., Chang, L. Y. X., Huang, H., Lin, T.-C., Chyan, C. L., & Chen, Y. C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.026 · Cited by 90
E2-25K/Hip-2 regulates caspase-12 in ER stress–mediated Aβ neurotoxicity
Song, S., Lee, H., Kam, T., Tai, M. L., Lee, J., Noh, J.-Y., Shim, S. M., Seo, S. J., Kong, Y., Nakagawa, T., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711066 · Cited by 90
Diosmin reduces cerebral Aβ levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice
Sawmiller, D. R., Habib, A., Li, S., Darlington, D., Hou, H., Tian, J., Shytle, R. D., de Smith, A. J., Giunta, B. N., Mori, T., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.018 · Cited by 92
Microglial signalling cascades in neurodegenerative disease
Pocock, J. M., & Liddle, A. C. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32103-9 · Cited by 91
The Expression of Creatine Kinase Isoenzymes in Neocortex of Patients with Neurodegenerative Disorders: Alzheimer's and Pick's Disease
Aksenov, M. Y., Aksenova, M. V., Payne, R. M., Smith, C. D., Markesbery, W. R., & Carney, J. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6550 · Cited by 90
Self-citation
Amyloid β-Peptide Disrupts Mitochondrial Membrane Lipid and Protein Structure: Protective Role of Tauroursodeoxycholate
Rodrigues, C. M. P., Solá, S., Brito, M. A., Brondino, C. D., Brites, D. M. T. O., & Moura, J. J. G. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4370 · Cited by 90
Oxidative stress and neural dysfunction in Down Syndrome
Iannello, R. C., Crack, P. J., de Haan, J. B., & Kola, I. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_17 · Cited by 90
Quantitative imaging of tyrosine hydroxylase and calmodulin in the human brain
Sutoo, D., Akiyama, K., & Yabe, K. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010301)63:5 · Cited by 17
Self-citation
Glial Glutamine Homeostasis in Health and Disease
Andersen, J. V., & Schousboe, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03771-1 · Cited by 92
NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?
Croce, N., Gelfo, F., Ciotti, M. T., Federici, G., Caltagirone, C., Bernardini, S., & Angelucci, F. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1567-0 · Cited by 90
Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down Syndrome and Alzheimer’s disease
Balcz, B., Kirchner, L., Cairns, N. J., Fountoulakis, M., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_15 · Cited by 88
Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo
Szczepanik, A. M., Rampe, D., & Ringheim, G. E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00240.x · Cited by 94
In vitro peroxidase oxidation induces stable dimers of β-amyloid (1-42) through dityrosine bridge formation
Galeazzi, L., Ronchi, P., Franceschi, C., & Giunta, S. (1999) · Amyloid · doi:10.3109/13506129908993282 · Cited by 87
Cyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration
Du, H., Guo, L., Wu, X., Sosunov, A. A., McKhann, G. M., Chen, J. X., & Yan, S. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.004 · Cited by 87
Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents Aβ25–35-induced reduction in BPRP in PC12 cells
Lin, Y.-H., Liu, A.-H., Wu, H., Westenbroek, C., Song, Q., Yu, H.-M., Horst, G. J. T., & Li, X.-J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.110 · Cited by 86
Free radical theory of aging: Alzheimer’s disease pathogenesis
Harman, D. (1995) · AGE · doi:10.1007/bf02436085 · Cited by 87
The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer’s Disease Etiopathology
Fanlo-Ucar, H., Picón-Pagès, P., Herrera-Fernández, V., ILL‐Raga, G., & Muñoz, F. J. (2024) · Antioxidants · doi:10.3390/antiox13101208 · Cited by 94
Apoptosis Signal-Regulating Kinase 1 in Amyloid β Peptide-Induced Cerebral Endothelial Cell Apoptosis
Hsu, M., Hsu, C. Y., Chen, B.-C., Chen, M.-C., Ou, G., & Lin, C. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1874-06.2007 · Cited by 85
Novel neuroprotective effects of the aqueous extracts from Verbena officinalis Linn
Lai, S.-W., Yu, M.-S., Yuen, W.-H., & Chang, R. C. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.009 · Cited by 85
Protective effects of huperzine A on β-amyloid25–35 induced oxidative injury in rat pheochromocytoma cells
Xiao, X., Wang, R., Han, Y., & Tang, X. C. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01088-0 · Cited by 85
Role of S-adenosylhomocysteine in cardiovascular disease and its potential epigenetic mechanism
Xiao, Y., Su, X., Huang, W. H., Zhang, J., Peng, C., Huang, H., Wu, X., Huang, H., Xia, M., & Ling, W. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.06.015 · Cited by 85
Increased Apoptotic Cell Death in Sporadic and Genetic Alzheimer's Disease
Eckert, A., Marques, C. A., Keil, U., Schüssel, K., & MÜLLER, W. E. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1299.113 · Cited by 86
Induction of Nitric Oxide Synthase and Microglial Responses Precede Selective Cell Death Induced by Chronic Impairment of Oxidative Metabolism
Calingasan, N. Y., Park, L. C. H., Calo, L. L., Trifiletti, R. R., Gandy, S., & Gibson, G. E. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65602-7 · Cited by 85
Neuroglobin protects PC12 cells against β-amyloid-induced cell injury
Li, R. C., Pouranfar, F., Lee, S. K., Morris, M. W., Wang, Y., & Gozal, D. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.001 · Cited by 85
In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β‐amyloid(1–42)‐induced cytotoxicity in differentiated PC12 cells
Kumar, S., Seal, C. J., Howes, M. R., Kite, G. C., & Okello, E. J. (2010) · Phytotherapy Research · doi:10.1002/ptr.3261 · Cited by 84
Melatonin prevents β‐amyloid‐induced lipid peroxidation
Daniels, W. M. U., van Rensburg, S. J., van Zyl, J. M., & Taljaard, J. J. F. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00370.x · Cited by 84
The calcium–iron connection in ferroptosis-mediated neuronal death
Gleitze, S., Paula-Lima, A. C., Núñez, M. T., & Hidalgo, C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.08.231 · Cited by 84
Icariin inhibits beta-amyloid peptide segment 25–35 induced expression of β-secretase in rat hippocampus
Nie, J., Luo, Y., Xie-nan, H., Gong, Q., Wu, Q., & Shi, J. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.039 · Cited by 83
Gender differences in glutathione metabolism in Alzheimer's disease
Liu, H., Harrell, L. E., Shenvi, S. V., Hagen, T. M., & Liu, R.-M. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20424 · Cited by 83
Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease?
Dib, M., Garrel, C., Favier, A. E., Robin, V., & Desnuelle, C. (2002) · Journal of Neurology · doi:10.1007/s004150200025 · Cited by 84
Thiamine deficiency increases β-secretase activity and accumulation of β-amyloid peptides
Zhang, Q., Yang, G., Li, W., Fan, Z., Sun, A., Luo, J., & Ke, Z. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.005 · Cited by 83
Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents
Li, X., Wang, H., Lu, Z., Zheng, X., Wei Min, N. I., Zhu, J., Fu, Y., Lian, F., Zhang, N., Li, J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00636 · Cited by 83
Aging and Regulation of Apoptosis
Warner, H. R. (1997) · Current topics in cellular regulation · doi:10.1016/s0070-2137(97)80004-0 · Cited by 82
β-Amyloid Neurotoxicity Is Exacerbated during Glycolysis Inhibition and Mitochondrial Impairment in the Rat Hippocampus in Vivo and in Isolated Nerve Terminals: Implications for Alzheimer's Disease
Arias, C., Montiel, T., Quiroz‐Baez, R., & Massieu, L. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7912 · Cited by 82
Puerarin protects PC12 cells against β‐amyloid‐induced cell injury
Zhang, H., Liu, Y., Wang, H., Xu, J., & Hu, H. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.07.006 · Cited by 81
β-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients
Calingasan, N. Y., Chen, J., Kiaei, M., & Beal, M. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.012 · Cited by 83
Therapeutic role of rifampicin in Alzheimer's disease
Yuluğ, B., Hanoğlu, L., Ozansoy, M., Isık, D., Kılıç, Ü., Kılıç, E., & Schabitz, W. R. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12637 · Cited by 81
Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease
Tripathi, A., Choubey, P. K., Sharma, P. A., Seth, A., Tripathi, P. N., Tripathi, M. K., Prajapati, S. K., Krishnamurthy, S., & Shrivastava, S. K. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111707 · Cited by 81
Copper reduction by copper binding proteins and its relation to neurodegenerative diseases
Opazo, C., Barría, M. I., Ruiz, F. H., & Inestrosa, N. C. (2003) · BioMetals · doi:10.1023/a:1020795422185 · Cited by 83
Degeneration of neuronal cells due to oxidative stress—microglial contribution
Koutsilieri, E., Scheller, C., Tribl, F., & Riederer, P. F. (2002) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00021-4 · Cited by 81
Oxidative Modification of Glutamine Synthetase by Amyloid Beta Peptide
Aksenov, M. Y., Aksenova, M. V., Carney, J. M., & Butterfield, D. A. (1997) · Free Radical Research · doi:10.3109/10715769709065765 · Cited by 81
Self-citation
Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease
Nunomura, A., Tamaoki, T., Tanaka, K., Motohashi, N., Nakamura, M., Hayashi, T., Yamaguchi, H., Shimohama, S., Lee, H., Zhu, X., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.012 · Cited by 82
The kinetics of oxidation of GSH by protein radicals
Nauser, T., Koppenol, W. H., & Gebicki, J. M. (2005) · Biochemical Journal · doi:10.1042/bj20050539 · Cited by 80
Amyloidosis of Alzheimer's Aβ peptides: solid‐state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies
Antzutkin, O. N. (2004) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.1341 · Cited by 80
The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease
Rottkamp, C. A., Atwood, C., Joseph, J. A., Nunomura, A., Perry, G. L., & Smith, M. A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00069-4 · Cited by 81
Is Oxidative Damage by β-Amyloid and Prion Peptides Mediated by Hydrogen Atom Transfer from Glycine α-Carbon to Methionine Sulfur within β-Sheets?
Rauk, A., Armstrong, D. A., & Fairlie, D. P. (2000) · Journal of the American Chemical Society · doi:10.1021/ja994436u · Cited by 79
Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain
Jope, R. S., Song, L., & Powers, R. E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00205-9 · Cited by 78
Amyloidosis in Alzheimer’s Disease: The Toxicity of Amyloid Beta (Aβ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy
Prasansuklab, A., & Tencomnao, T. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/413808 · Cited by 77
Increased Protein Oxidation and Decreased Creatine Kinase BB Expression and Activity after Spinal Cord Contusion Injury
Aksenova, M. V., Butterfield, D. A., Zhang, S., Underwood, M. Y., & Geddes, J. W. (2002) · Journal of Neurotrauma · doi:10.1089/08977150252932433 · Cited by 77
Self-citation
Quercetin Exerts Differential Neuroprotective Effects Against H2O2 and Aβ Aggregates in Hippocampal Neurons: the Role of Mitochondria
Godoy, J. A., Lindsay, C. B., Quintanilla, R. A., Carvajal, F. J., Cerpa, W. F., & Inestrosa, N. C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0203-x · Cited by 78
Aging and Caloric Restriction Affect Mitochondrial Respiration and Lipid Membrane Status: An Electron Paramagnetic Resonance Investigation
Gabbita, S. P., Butterfield, D. A., Hensley, K., Shaw, W., & Carney, J. M. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00043-9 · Cited by 77
Self-citation
Vitamin E protects against Alzheimer's amyloid peptide (25–35)-induced changes in neocortical synaptosomal membrane lipid structure and composition
Koppal, T., Subramaniam, R., Drake, J., Prasad, M. R., Dhillon, H. S., & Butterfield, D. A. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01466-2 · Cited by 77
Self-citation
Cholesterol, oxidative stress, and Alzheimer’s disease: expanding the horizons of pathogenesis1 1This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal.
Pappolla, M. A., Smith, M. A., Bryant‐Thomas, T., Bazan, N., Petanceska, S. S., Perry, G. L., Thal, L. J., Sano, M., & Refolo, L. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00841-9 · Cited by 78
Water-soluble derivative of propolis mitigates scopolamine-induced learning and memory impairment in mice
Chen, J., Long, Y., Han, M., Wang, T., Chen, Q., & Wang, R. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.03.029 · Cited by 76
Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease
Bhatia, S., Knoch, B., Wong, J., Kim, W. S., Else, P. L., Oakley, A. J., & Garner, B. (2011) · Biochemical Journal · doi:10.1042/bj20111166 · Cited by 78
Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease
Luo, Y. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3407 · Cited by 76
Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids
Jolivalt, C. G., Leininger‐Muller, B., Bertrand, P., Herber, R., Christen, Y., & Siest, G. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00232-4 · Cited by 76
Neurodegenerative mechanisms in alzheimer disease
Sopher, B. L., Fukuchi, K., Kavanagh, T. J., Furlong, C. E., & Martin, G. M. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02814999 · Cited by 75

Authors: Hensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A.
Affiliations: University of Kentucky (US)
Department of Chemistry, University of Kentucky, Lexington 40506.
ORCID: Mattson, M P
Aksenova, M
Butterfield, D A
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1994-04-12
Volume: 91
Issue: 8
Pages: 3270-3274
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.91.8.3270
PMC: PMC43558
OpenAlex: W2070117026
Cited by: 1,086
References: 23
Citations by year: 2026: 6 · 2025: 12 · 2024: 20 · 2023: 16 · 2022: 21 · 2021: 26 · 2020: 15 · 2019: 18 · 2018: 26 · 2017: 15 · 2016: 23 · 2015: 27 · 2014: 26 · 2013: 32 · 2012: 34
FWCI: 35.21
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Science Foundation (9108764)
Glenn Foundation for Medical Research
Fondation pour la Recherche Médicale
National Institutes of Health (AG-10836)
National Institute on Aging (AG 09690, P01AG010836, R01AG009690, AG 10836)
Office of Naval Research
National Institute of Neurological Disorders and Stroke (R01NS023307, NS-23307)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Keywords: amyloid-beta, amyloid fibril formation, neurotoxicity, free radicals, reactive oxygen species, glutamine synthetase, creatine kinase, salicylate hydroxylation, amyloid plaques, Alzheimer's disease, peptide fragmentation, membrane alterations
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Chromatography, High Pressure Liquid, Electron Spin Resonance Spectroscopy, Free Radicals, Gas Chromatography-Mass Spectrometry, Molecular Sequence Data, Neurotoxins, Salicylates, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks